Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps Article

sustainable development goals

publication date

  • November 8, 2024

webpage

published in

keywords

  • Asthma
  • Biologic
  • Chronic rhinosinusitis
  • Nasal polyps
  • Sino-Nasal Outcome Test-22
  • Tezepelumab
  • Thymic stromal lymphopoietin